Ra Medical Systems
2070 Las Palmas Dr.
Carlsbad
California
92011
United States
Tel: 877-635-1800 or 760-804-1648
Fax: 760-804-1657
Website: http://www.ramed.com/
Email: info@ramed.com
115 articles about Ra Medical Systems
-
Ra Medical Systems Announces First Quarter 2023 Results
6/2/2023
Ra Medical Systems, Inc. announced financial and company highlights for the first quarter ended March 31,2023.
-
Ra Medical Electrophysiology Division is Participating in EHRA Congress
4/17/2023
Ra Medical Systems, Inc. (NYSE American:RMED) announced today that its wholly owned subsidiary, Catheter Precision, Inc., participates in the European Heart Rhythm Association (EHRA). EHRA will take place in Barcelona, Spain from April 16-18.
-
Ra Medical Systems Announces Date of Special Shareholder Meeting
2/10/2023
Ra Medical Systems (NYSE American:RMED) today announced the date of March 21, 2023 as the date of its special shareholder meeting.
-
Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress
1/23/2023
Ra Medical Systems, Inc. (NYSE American: RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that four abstracts with clinical data supporting its VIVO technology have been accepted for presentation at the European Heart Rhythm Association Congress (EHRA 2023) being held April 16-18, 2023 in Barcelona.
-
Ra Medical Systems Realigns Its Board of Directors
1/17/2023
Ra Medical Systems (NYSE American: RMED) announces a realignment of its board of directors in conjunction with the recently announced merger with Catheter Precision, Inc. David Jenkins has joined the board as Executive Chairman and James Caruso has been named director.
-
Ra Medical Systems Completes Merger with Catheter Precision
1/10/2023
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its previously announced stock-for-stock merger transaction with Catheter Precision, Inc., a company focused on the cardiac electrophysiology market.
-
Ra Medical Systems Regains Compliance with NYSE American Continued Listing Standards
12/14/2022
Ra Medical Systems, Inc. announces that it has received notification from the NYSE American LLC that the Company has regained compliance with the NYSE American’s continued listing standard.
-
Ra Medical Systems Reports Third Quarter 2022 Financial Results
11/14/2022
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and nine months ended September 30, 2022 and provides a business update.
-
Ra Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock Split
9/20/2022
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces that at its virtual Special Meeting of Stockholders held today, the Company’s stockholders approved all three proposals on the proxy filed with the Securities and Exchange Commission on August 29, 2022.
-
Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
9/12/2022
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces it has entered into an Agreement and Plan of Merger (the “Definitive Merger Agreement”) with privately held Catheter Precision, Inc. (“Catheter Precision”), a medical device and technology company focused in the field of cardiac electrophysiology.
-
Ra Medical Systems Receives NYSE American Notice
9/2/2022
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that on August 31, 2022, it received a notice (the “Notice”) that the NYSE American LLC has determined the Company’s securities have been selling at a low price per share for a substantial period of time.
-
Ra Medical Systems Reports Second Quarter 2022 Financial Results
8/15/2022
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and six months ended June 30, 2022 and provides a business update.
-
Ra Medical Systems Provides Update on its Annual Filings
8/1/2022
Ra Medical Systems, Inc. announces that its audited consolidated financial statements for the fiscal year ended December 31, 2021 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 24, 2022 and Amended Form 10-K/A filed with the SEC on July 7, 2022 contained an audit report from its independent registered public accounting firm which included a going concern emphasis of matter paragraph.
-
Ra Medical Systems Enters Into Agreements to Raise $6.2 Million Through Previously Issued Warrants and Plans Strategic Merger with Catheter Precision Inc.
7/22/2022
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces a reduction in the exercise price of all existing warrants that were issued in the February 2022 public offering, consisting of Series A Warrants and Series B Warrants, from $0.50 per share to $0.28 per share.
-
Ra Medical Systems Appoints Brian D. Conn Interim Chief Financial Officer
7/18/2022
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the appointment of Brian D. Conn as interim Chief Financial Officer, effective immediately.
-
Ra Medical Systems Receives FDA 510(k) Clearance for the DABRA 2.0 Catheter
7/5/2022
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces receipt of U.S. Food and Drug Administration 510(k) clearance for the Company’s DABRA 2.0 catheter.
-
Ra Medical Systems Reports First Quarter 2022 Financial Results
5/16/2022
Ra Medical Systems, Inc., a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months ended March 31, 2022 and provides a business update.
-
Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022
5/9/2022
Ra Medical Systems, Inc . (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16.
-
Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area
4/5/2022
Ra Medical Systems, Inc. announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser ablation catheters with expanded distal optical windows.
-
Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results
3/23/2022
Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months and full year ended December 31, 2021 and provides a business update.